tirzepatide forms How to Source for Pharmaceutical Formulation Oral vs injectable tirzepatide: which

Imai, H

Researchers considering switching from tirzepatide to retatrutide should know that the thyroid risk profile is expected to be similar based on the shared GLP-1 receptor agonist mechanism

From there, the dose can continue increasing to 10 mg, 12.5 mg, and ultimately 15 mg if needed and tolerated

Maintenance (weight reduction and long-term maintenance): The recommended maintenance dosages are 5 mg, 10 mg, or 15 mg once weekly Maintenance (OSA): The recommended maintenance dosages are 10 mg or 15 mg once weekly Maximum: 15 mg once weekly Inject subcutaneously in the abdomen, thigh, or upper arm at any time of day, with or without meals